SION FY 2024 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SIONSionna Therapeutics, Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$668,000

Operating Income

-$71M

Net Income

-$62M

EPS (Diluted)

$-1.40

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$53M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$186M

Total Liabilities

$349M

Stockholders' Equity

-$164M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$668,000	$0	—
Operating Income	-$71M	-$50M	-40.2%
Net Income	-$62M	-$47M	-30.5%